AGL 8.15 No Change ▼ 0.00 (0%)
ANL 11.45 Increased By ▲ 0.36 (3.25%)
AVN 83.75 Increased By ▲ 0.05 (0.06%)
BOP 5.80 Decreased By ▼ -0.05 (-0.85%)
CNERGY 5.78 Increased By ▲ 0.13 (2.3%)
EFERT 79.95 Decreased By ▼ -0.27 (-0.34%)
EPCL 67.10 Decreased By ▼ -0.18 (-0.27%)
FCCL 15.05 Decreased By ▼ -0.15 (-0.99%)
FFL 7.20 Decreased By ▼ -0.03 (-0.41%)
FLYNG 7.83 Decreased By ▼ -0.23 (-2.85%)
GGGL 11.96 Decreased By ▼ -0.04 (-0.33%)
GGL 17.66 Decreased By ▼ -0.05 (-0.28%)
GTECH 9.15 Increased By ▲ 0.37 (4.21%)
HUMNL 7.33 Increased By ▲ 0.10 (1.38%)
KEL 3.64 Decreased By ▼ -0.10 (-2.67%)
LOTCHEM 31.60 Decreased By ▼ -0.50 (-1.56%)
MLCF 28.74 Decreased By ▼ -0.26 (-0.9%)
OGDC 85.25 Decreased By ▼ -0.80 (-0.93%)
PAEL 17.21 Decreased By ▼ -0.19 (-1.09%)
PIBTL 6.30 No Change ▼ 0.00 (0%)
PRL 19.54 Increased By ▲ 0.44 (2.3%)
SILK 1.32 Increased By ▲ 0.13 (10.92%)
TELE 12.06 Decreased By ▼ -0.19 (-1.55%)
TPL 9.22 Increased By ▲ 0.04 (0.44%)
TPLP 20.42 Decreased By ▼ -0.28 (-1.35%)
TREET 27.00 Increased By ▲ 0.05 (0.19%)
TRG 97.90 Increased By ▲ 0.15 (0.15%)
UNITY 22.82 Decreased By ▼ -0.18 (-0.78%)
WAVES 13.40 Decreased By ▼ -0.70 (-4.96%)
WTL 1.45 Increased By ▲ 0.14 (10.69%)
BR100 4,372 Decreased By -16.1 (-0.37%)
BR30 16,081 Decreased By -18.3 (-0.11%)
KSE100 43,503 Decreased By -173.2 (-0.4%)
KSE30 16,489 Decreased By -43.3 (-0.26%)

Moderna Inc

Moderna testing new COVID-19 vaccine as potential booster shot

Moderna testing new COVID-19 vaccine as potential booster shot

  • The early-stage study will assess the safety and immunogenicity of mRNA-1283 at three dose levels, and will be given to healthy adults either as a single dose or in two doses 28 days apart, the company said.
  • Last week, Moderna began dosing the first participants in a study testing its COVID-19 booster vaccine candidates.
Updated 15 Mar, 2021 09:25pm
Merck to help make Johnson & Johnson's COVID-19 vaccine
Business & Finance

Merck to help make Johnson & Johnson's COVID-19 vaccine

  • After scrapping development of its own COVID-19 vaccine candidates in January, Merck last month said it was working on a deal to open up its manufacturing capacity to other vaccine makers.
  • J&J is shipping about four million doses of its vaccine in the United States this week, but the next shipments hinge on when its new, larger manufacturing plant receives regulatory approvals.
Published 02 Mar, 2021 08:34pm
Japanese shares gain
Markets

Japanese shares gain

TOKYO: Japanese shares rose on Monday, erasing early losses, led by tech and pharma stocks as US futures rose on...
Published 26 Jan, 2021 05:05am
Britain approves Moderna's COVID-19 vaccine for use
World

Britain approves Moderna's COVID-19 vaccine for use

  • Three COVID-19 vaccines have now been approved for use in Britain, with Pfizer/BioNTech's shot and one developed by Oxford University and AstraZeneca already being rolled out.
  • We have already vaccinated nearly 1.5 million people across the UK and Moderna's vaccine will allow us to accelerate our vaccination programme
Published 08 Jan, 2021 06:54pm
Britain approves Moderna's COVID-19 vaccine for use
Business & Finance

Britain approves Moderna's COVID-19 vaccine for use

  • Three COVID-19 vaccines have now been approved for use in Britain, with Pfizer//BioNTech's shot and one developed by Oxford University and AstraZeneca already being rolled out.
  • Moderna's vaccine was 94% effective in preventing disease in late-stage clinical trials.
Published 08 Jan, 2021 06:00pm
Israel authorises use of Moderna's COVID-19 vaccine
World

Israel authorises use of Moderna's COVID-19 vaccine

  • Ministry of Health of Israel has secured 6 million doses and first deliveries (are) expected to begin in January.
  • Israeli Health Minister Yuli Edelstein said he had no knowledge of shipments arriving this month.
Published 05 Jan, 2021 05:31pm